PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Medulloblastoma
Related studies linked through entity extraction aliases.
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
- Status
- TERMINATED
- Phase
- N/A
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
- Status
- RECRUITING
- Phase
- N/A
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection
- Status
- UNKNOWN
- Phase
- PHASE2
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Status
- RECRUITING
- Phase
- NA
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1